![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA APPROVES IMPLANON (ETONOGESTREL IMPLANT) 68MG, THE FIRST AND ONLY SINGLE-ROD IMPLANTABLE CONTRACEPTIVE
FDA APPROVES IMPLANON (ETONOGESTREL IMPLANT) 68MG, THE FIRST AND ONLY SINGLE-ROD IMPLANTABLE CONTRACEPTIVE
July 18, 2006
Organon announced that the U.S. Food and Drug Administration (FDA) approved IMPLANON (etonogestrel implant) 68mg, the first and only single-rod implantable contraceptive that is effective for up to three years. PRNewswire (http://www.drugnewswire.com/3509/)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct